BRIEF-AVEO Says EUSA Pharma Granted Positive NICE Recommendation For Fotivda
February 12, 2018 at 07:26 AM EST
* AVEO ANNOUNCES EUSA PHARMA GRANTED POSITIVE NICE RECOMMENDATION FOR FOTIVDA® (TIVOZANIB) AS FIRST LINE TREATMENT FOR ADVANCED RENAL CELL CARCINOMA